Nootropics
Evidence: moderate_human
Atypical dopamine reuptake inhibitor with additional phenethylamine-like stimulatory properties. Increases the density of acetylcholine, NMDA, GABA, and dopamine receptors in the brain. The phenyl group addition to the piracetam backbone enables blood-brain barrier penetration at 20-60x greater potency than piracetam, with added psychostimulant and cold-tolerance properties.
Standard: 100-300 mg/day divided into 1-2 doses
Maintenance: 100-200 mg/day
Administration: oral
Timing: Morning or early afternoon; avoid evening use due to stimulant effects. Take with or without food.
Duration: Use sparingly — tolerance develops rapidly. Best cycled 2 weeks on, 2 weeks off, or reserved for acute-need situations.
Banned by WADA — athletes must be aware. Tolerance develops within days of continuous use, making it unsuitable for daily supplementation. Best reserved as an acute performance enhancer for demanding days. The R-isomer appears to be primarily responsible for the nootropic effects while the S-isomer drives the stimulant properties.
Banned by WADA as a performance-enhancing substance. Source from vendors with CoA. Russian pharmaceutical-grade (Phenotropil/Nanotropil brand) was discontinued; rely on research chemical vendors with analytical verification.
Take the free assessment and get personalized recommendations based on your biology and goals.
Get Your Free Protocolor take the assessment →